These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 36812441)
1. Safety and Efficacy of Denosumab for Fibrous Dysplasia of Bone. de Castro LF; Michel Z; Pan K; Taylor J; Szymczuk V; Paravastu S; Saboury B; Papadakis GZ; Li X; Milligan K; Boyce B; Paul SM; Collins MT; Boyce AM N Engl J Med; 2023 Feb; 388(8):766-768. PubMed ID: 36812441 [No Abstract] [Full Text] [Related]
2. Successful treatment with denosumab for pelvic fibrous dysplasia: A case report and review of the literature. Ikuta K; Sakai T; Koike H; Ito K; Imagama S; Nishida Y Medicine (Baltimore); 2021 Dec; 100(49):e28138. PubMed ID: 34889277 [TBL] [Abstract][Full Text] [Related]
3. Denosumab for Fibrous Dysplasia: Promising, but Questions Remain. Collins MT; de Castro LF; Boyce AM J Clin Endocrinol Metab; 2020 Nov; 105(11):e4179-80. PubMed ID: 32478399 [No Abstract] [Full Text] [Related]
4. Denosumab Treatment for Giant Cell Tumors, Aneurysmal Bone Cysts, and Fibrous Dysplasia-Risks and Benefits. Pan KS; Boyce AM Curr Osteoporos Rep; 2021 Apr; 19(2):141-150. PubMed ID: 33616817 [TBL] [Abstract][Full Text] [Related]
5. Letter regarding - Denosumab use in bone fibrous dysplasia refractory to bisphosphonate: A retrospective multicentric study. Theodorou DJ; Theodorou SJ; Tzimas V; Korompilias AV Bone; 2023 Oct; 175():116853. PubMed ID: 37473932 [No Abstract] [Full Text] [Related]
6. Rapid biochemical response to denosumab in fibrous dysplasia of bone: report of two cases. Ganda K; Seibel MJ Osteoporos Int; 2014 Feb; 25(2):777-82. PubMed ID: 24311113 [TBL] [Abstract][Full Text] [Related]
7. Denosumab Use in Adults With Fibrous Dysplasia: Case Reports and Review of the Literature. Hung C; Shibli-Rahhal A Endocr Pract; 2022 Nov; 28(11):1196-1201. PubMed ID: 35952985 [TBL] [Abstract][Full Text] [Related]
8. Fibrous dysplasia. Clinical review and therapeutic management. Florez H; Peris P; Guañabens N Med Clin (Barc); 2016 Dec; 147(12):547-553. PubMed ID: 27765282 [TBL] [Abstract][Full Text] [Related]
9. Treatment of fibrous dysplasia: focus on denosumab. Huzum B; Antoniu S; Dragomir R Expert Opin Biol Ther; 2022 Mar; 22(3):397-405. PubMed ID: 34964677 [TBL] [Abstract][Full Text] [Related]
10. A case of recalcitrant fibrous dysplasia treated with denosumab. Gautam KP; Rajan R; Cherian KE; Kapoor N; Hephzibah J; Paul TV Joint Bone Spine; 2020 Jul; 87(4):369-370. PubMed ID: 32279999 [No Abstract] [Full Text] [Related]
11. Clinical and translational pharmacological aspects of the management of fibrous dysplasia of bone. Rotman M; Hamdy NAT; Appelman-Dijkstra NM Br J Clin Pharmacol; 2019 Jun; 85(6):1169-1179. PubMed ID: 30471134 [TBL] [Abstract][Full Text] [Related]